scholarly journals Cost-Effectiveness of Ceritinib In Previously Untreated ALK-Positive Non-Small Cell Lung Cancer in the United Kingdom

2018 ◽  
Vol 21 ◽  
pp. S29
Author(s):  
J Xie ◽  
S Knoll ◽  
A Slowley ◽  
A Bensimon ◽  
J Vieira ◽  
...  
Keyword(s):  
Lung Cancer ◽  
United Kingdom ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
The United Kingdom ◽  
Alk Positive

Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China

2019 ◽  
Vol 36 (5) ◽  
pp. 1114-1125 ◽  
Author(s):  
Haijing Guan ◽  
Yanan Sheng ◽  
Wanjie Guo ◽  
Sheng Han ◽  
Luwen Shi
Keyword(s):  
Lung Cancer ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Positive
Sign in / Sign up

Export Citation Format

Share Document